Examining the evidence: complementary adjunctive therapies for multiple sclerosis. - Wikidata - wikimedia - TriplyDB

Examining the evidence: complementary adjunctive therapies for multiple sclerosis.

Examining the evidence: complementary adjunctive therapies for multiple sclerosis.

http://www.wikidata.org/entity/Q37217845

about

Dietary interventions for multiple sclerosis Pharmacological Alternatives for the Treatment of Neurodegenerative Disorders: Wasp and Bee Venoms and Their Components as New Neuroactive Tools Clinical implications of a possible role of vitamin D in multiple sclerosis Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta.The Liberation Procedure Decision-Making Experience for People With Multiple Sclerosis.

P2860

Q24202428-1C99C9FC-6F65-4678-A618-2FC95234CF86 Q26795786-D0CE4D2A-1BC1-4216-8CDF-8FAD4FFF10B5 Q34607012-A888CDD3-9A28-417C-B8BA-00A86DEBC803 Q37402058-1A989A84-F41A-4DB9-87CB-111A79A1A144 Q37619149-CF20DA4E-7E30-49C6-87E2-44196276F7AA

P2860

Examining the evidence: complementary adjunctive therapies for multiple sclerosis.

http://www.wikidata.org/entity/Q37217845

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 July 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Examining the evidence: complementary adjunctive therapies for multiple sclerosis.

@en

Examining the evidence: complementary adjunctive therapies for multiple sclerosis.

@nl

type

label

Examining the evidence: complementary adjunctive therapies for multiple sclerosis.

@en

Examining the evidence: complementary adjunctive therapies for multiple sclerosis.

@nl

prefLabel

Examining the evidence: complementary adjunctive therapies for multiple sclerosis.

@en

Examining the evidence: complementary adjunctive therapies for multiple sclerosis.

@nl

P1433

Q37217845-015DF68B-908C-4B6E-89B2-4BAA23ADB84D

P1476

Q37217845-048F55FD-2B05-4756-B6D8-2F8371EB8465

P2093

Q37217845-21129518-E087-4F68-B6B2-5C43876DC037

Q37217845-2A049C39-6B6F-4D1A-AB5B-9263442C2327

Q37217845-3285DE62-3089-4BE8-947C-97230CA2BCE2

Q37217845-5EF171FA-084B-4888-BD64-82E171A66D58

Q37217845-83B71ACE-9CD4-4353-89E6-86099E094C2C

Q37217845-A554ADFD-66C1-49F8-947B-BAB91252FE77

Q37217845-A8FB6C69-D0F5-4229-A3D5-6BABD1FE6A0B

Q37217845-BA035D89-1197-40C8-BB43-2DBADCD685E3

Q37217845-C52FEAAA-8ADA-4007-BF48-9004ACD970A4

P2860

Q37217845-00952668-6688-4E35-A5F1-0D3DEA6A7408

Q37217845-01459611-AF4A-41FE-9CFE-A432590F0167

Q37217845-030D64CB-C2DA-4C7B-832E-B52B4019419C

Q37217845-046505B0-0B11-43B6-8904-D70CC9C5839F

Q37217845-07EA4748-F498-457D-B52B-355D1F559A30

Q37217845-0B6B6FDF-6EE0-4A27-BC5E-E097838D109A

Q37217845-0F6ACCE5-4866-4AFB-8529-8037CBE79CDB

Q37217845-11187BD4-CDF1-4701-9945-A4AA1C56CEFC

Q37217845-117B0824-4465-465D-9330-322BA52CC860

Q37217845-1525B920-58A9-414D-A347-7BB61844875C

P304

Q37217845-68AC8CDB-D527-4F17-B17D-E78D90C1ED88

P31

Q37217845-E895D2EF-E9FF-4C03-AB4A-3A134A0A9FA6

P356

Q37217845-D0FF0389-46B8-41B3-AB79-2E4AB8237824

P433

Q37217845-E9FB7BB2-BA0B-4620-B7E1-7A8AD66E0F57

P478

Q37217845-A8B2C867-0270-44AF-8E62-EBF200421099

P577

Q37217845-0D86B6DB-C27D-46C3-8FB0-F45C4D10A551

P698

Q37217845-E3ECFB0B-B3B7-4ACE-9DFE-AF21F5B6B59E

P921

Q37217845-544EF6BA-FABC-4CF7-9FC7-6D5D0C580D25

P356

174313208X325038

P1433

Neurological Research

P1476

Examining the evidence: complementary adjunctive therapies for multiple sclerosis.

@en

P2093

Alicja Wojewnik-Smith

http://www.w3.org/2001/XMLSchema#string

Andrea Doupe

http://www.w3.org/2001/XMLSchema#string

Arla Crook

http://www.w3.org/2001/XMLSchema#string

Kulwinder Kler

http://www.w3.org/2001/XMLSchema#string

Marcus Vasconcelos

http://www.w3.org/2001/XMLSchema#string

Maria Melanson

http://www.w3.org/2001/XMLSchema#string

Meghann Klowak

http://www.w3.org/2001/XMLSchema#string

Mike Namaka

http://www.w3.org/2001/XMLSchema#string

Yuewen Gong

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

Multiple sclerosis

Proinflammatory cytokines regulate antigen-independent T-cell activation by two separate calcium-signaling pathways in multiple sclerosis patients.

Immunopathogenesis of multiple sclerosis: the role of T cells.

Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin.

New clues about vitamin D functions in the nervous system.

Cytokine profile in patients with multiple sclerosis following vitamin D supplementation.

Vitamin D intake and incidence of multiple sclerosis.

P304

710-719

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1179/174313208X325038

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18631428

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis